Literature DB >> 19690354

Patient and staff doses for some complex x-ray examinations.

T Olgar1, D Bor, G Berkmen, T Yazar.   

Abstract

The aim of this study was to measure patient and staff doses simultaneously for some complex x-ray examinations. Measurements of dose-area product (DAP) and entrance skin dose (ESD) were carried out in a sample of 107 adult patients who underwent different x-ray examinations such as double contrast barium enema (DCBE), single contrast barium enema (SCBE), barium swallow, endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC), and various orthopaedic surgical procedures. Dose measurements were made separately for each projection, and DAP, thermoluminescent dosimetry (TLD), film dosimetry and tube output measurement techniques were used. Staff doses were measured simultaneously with patient doses for these examinations, with the exception of barium procedures. The measured mean DAP values were found to be 8.33, 90.24, 79.96 Gy cm(2) for barium swallow, SCBE and DCBE procedures with the fluoroscopy times of 3.1, 4.43 and 5.86 min, respectively. The calculated mean DAP was 26.33 Gy cm(2) for diagnostic and 89.76 Gy cm(2) therapeutic ERCP examinations with the average fluoroscopy times of 1.9 and 5.06 min respectively. Similarly, the calculated mean DAP was 97.53 Gy cm(2) with a corresponding fluoroscopy time of 6.1 min for PTC studies. The calculated mean entrance skin dose (ESD) was 172 mGy for the orthopaedic surgical studies. Maximum skin doses were measured as 324, 891, 1218, 750, 819 and 1397 mGy for barium swallow, SCBE, DCBE, ERCP, PTC and orthopaedic surgical procedures, respectively. The high number of radiographs taken during barium enema examinations, and the high x-ray outputs of the fluoroscopic units used in ERCP, were the main reasons for high doses, and some corrective actions were immediately taken.

Entities:  

Mesh:

Year:  2009        PMID: 19690354     DOI: 10.1088/0952-4746/29/3/004

Source DB:  PubMed          Journal:  J Radiol Prot        ISSN: 0952-4746            Impact factor:   1.394


  7 in total

1.  The impact of endoscopic retrograde cholangiopancreatography education on radiation exposure to experienced endoscopist: 'trainee effect'.

Authors:  Erkin Oztas; Erkan Parlak; Fahrettin Kucukay; Mehmet Arhan; Ulku Daglı; Digdem Ozer Etik; Fatih Oguz Onder; Tulay Olcer; Nurgul Sasmaz
Journal:  Dig Dis Sci       Date:  2012-05       Impact factor: 3.199

Review 2.  Personal dosimetry for interventional operators: when and how should monitoring be done?

Authors:  C J Martin
Journal:  Br J Radiol       Date:  2010-12-15       Impact factor: 3.039

Review 3.  Occupational radiation doses to operators performing fluoroscopically-guided procedures.

Authors:  Kwang Pyo Kim; Donald L Miller; Amy Berrington de Gonzalez; Stephen Balter; Ruth A Kleinerman; Evgenia Ostroumova; Steven L Simon; Martha S Linet
Journal:  Health Phys       Date:  2012-07       Impact factor: 1.316

Review 4.  Evolution of radiation protection for medical workers.

Authors:  John Boice; Lawrence T Dauer; Kenneth R Kase; Fred A Mettler; Richard J Vetter
Journal:  Br J Radiol       Date:  2020-06-04       Impact factor: 3.039

5.  Attitudes to radiation safety and cholangiogram interpretation in endoscopic retrograde cholangiopancreatography (ERCP): a UK survey.

Authors:  Keith Siau; George Webster; Mark Wright; Ben Maher; Brian Stedman; Gavin Johnson; Saqib Ahmad; Nadeem Tehami
Journal:  Frontline Gastroenterol       Date:  2020-12-11

Review 6.  The radiation doses and radiation protection on the endoscopic retrograde cholangiopancreatography procedures.

Authors:  Mamoru Takenaka; Makoto Hosono; Shiro Hayashi; Tsutomu Nishida; Masatoshi Kudo
Journal:  Br J Radiol       Date:  2021-08-11       Impact factor: 3.629

Review 7.  How should radiation exposure be handled in fluoroscopy-guided endoscopic procedures in the field of gastroenterology?

Authors:  Mamoru Takenaka; Makoto Hosono; Shiro Hayashi; Tsutomu Nishida; Masatoshi Kudo
Journal:  Dig Endosc       Date:  2022-01-12       Impact factor: 6.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.